GetTopicDetailResponse(id=f22e9382e33, topicName=輸血依賴性β-地中海貧血, introduction=輸血依賴性β-地中海貧血, content=null, image=null, comments=2, allHits=1119, url=https://h5.medsci.cn/topic?id=93827, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88302, tagList=[TagDto(tagId=88302, tagName=輸血依賴性β-地中海貧血)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1542671, encodeId=d1a315426e1b9, content=<a href='/topic/show?id=f22e9382e33' target=_blank style='color:#2F92EE;'>#輸血依賴性β-地中海貧血#</a>, objectTitle=藍鳥生物宣布在德國推出一次性的基因療法ZYNTEGLO（編碼βA-T87Q-globin基因的自體CD34 +細胞），用于治療輸血依賴性β-地中海貧血, objectType=article, longId=186375, objectId=80711863e538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80711863e538, replyNumber=0, likeNumber=69, createdTime=2020-01-18, rootId=0, userName=124985dbm10(暫無昵稱), userId=c3b113427229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80711863e538, moduleTitle=藍鳥生物宣布在德國推出一次性的基因療法ZYNTEGLO（編碼βA-T87Q-globin基因的自體CD34 +細胞），用于治療輸血依賴性β-地中海貧血, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=80711863e538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542670, encodeId=189e15426e040, content=<a href='/topic/show?id=f22e9382e33' target=_blank style='color:#2F92EE;'>#輸血依賴性β-地中海貧血#</a>, objectTitle=歐洲CHMP推薦將Bluebird公司的基因療法Zynteglo用于治療輸血依賴性β-地中海貧血, objectType=article, longId=163435, objectId=ce74163435a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce74163435a9, replyNumber=0, likeNumber=87, createdTime=2019-04-03, rootId=0, userName=124985dbm10(暫無昵稱), userId=c3b113427229, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce74163435a9, moduleTitle=歐洲CHMP推薦將Bluebird公司的基因療法Zynteglo用于治療輸血依賴性β-地中海貧血, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ce74163435a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
